Chapter 353 - 235: Two Academicians

Chapter 353: Chapter 235: Two Academicians

Jiang Keji, scholar of the Jin Country Academy of Sciences, professor, and doctoral supervisor.

He is the current deputy director (acting director) of the Jin Country Cardiovascular Disease Center, and the dean of the Jin Country Medical Science Academy Fuwai Cardiovascular Disease Hospital.

Director of the State Key Laboratory of Cardiovascular Diseases, Director of the Jin Country National Clinical Research Center for Cardiovascular Diseases, Editor-in-Chief of the Jin Country Circulation Journal, and a foreign scholar of the French Academy of Medicine.

Since 2001, he has been a key participant and leader in the development of coronary heart disease surgery at Fuwai Cardiovascular Hospital, actively conducting clinical research and promoting coronary artery bypass grafting.

He also undertook a special research project from the Science and Technology Bureau: "Research on an Integrated Evaluation System for the Technical Operating Procedures in the Diagnosis and Treatment of Cardiovascular and Lung Tumors."

He possessed profound research expertise in intravascular stent technology and heart valve transplantation.

This was precisely the direction Wu Ting was preparing to research, and it was also the field needed to address Lou Musaang’s current complex condition.

Wu Ting thought for a moment. ’After the conference, I’ll see if I can contact Jiang Ming. If I’m lucky, I could show Lou Musaang’s case file to Scholar Jiang and ask for his opinion.’

’Perhaps I’ll get a whole new line of thinking or direction. And I can also report on my latest research into bioresorbable stents to Scholar Jiang.’

Just as Wu Ting finished looking up information on Scholar Jiang, he heard some good news.

Scholar Jiang announced:

"...The next selected guideline is ’Clinical Guidelines for the Early Diagnosis of Hepatitis B-Related Primary Hepatocellular Carcinoma Based on Peripheral Blood PT, APTT, and PLT Levels’ by Dr. Wu Ting, Associate Chief of Hepatic Tumor Surgery at Fan City First Hospital..."

Hearing that Wu Ting had been selected, Dean Liu Rong began to applaud in congratulations.

The other experts who knew Wu Ting also looked toward the young man and applauded.

Jiang Ming looked at Wu Ting’s youthful face, feeling incredibly envious. ’It hasn’t even been that long since I last saw him! Not only did the guy get selected to write clinical guidelines, but he also got promoted to associate chief physician.’

A short while later, Scholar Jiang finished announcing the list of those selected to write the new guidelines.

Next, they began to discuss the writing plan for each selected guideline. It was a long-term process; what had been selected now was merely a first draft, a general direction for a clinical problem.

The actual writing of the guidelines still had a long way to go.

To advance the guideline writing process systematically, comprehensively, and efficiently, the conference began to form a specific guideline development group for each topic. The members included clinical experts, guideline technicians, patient representatives, health economists, pharmacologists, and other personnel.

Unsurprisingly, Wu Ting was selected as the clinical expert for his own guideline. For a long time to come, he would be working with the other members to complete the writing process.

A clinical expert as young as Wu Ting was a rare sight at the conference, and because of this, he once again drew the attention of many.

During the coffee break, Scholar Zeng and Scholar Jiang, who were on the rostrum, started talking about Wu Ting.

"That young fellow, Wu Ting, is quite interesting. He previously worked with my student, Ma Mengchao, and made significant contributions to the field of hepatobiliary surgery. His selection for the liver cancer guideline compilation this time is a form of recognition and praise for him. It’s also a positive step forward for our field of liver cancer research..."

Scholar Zeng held Wu Ting in high regard. After all, Wu Ting’s achievements in hepatobiliary surgery were tangible and clear to see.

Furthermore, since Wu Ting had some connection to his student, Ma Mengchao, his impression of him was also quite good.

Scholar Jiang glanced at Wu Ting in the distance and said coolly,

"Then congratulations are in order, Scholar Zeng, for producing such a remarkable young talent in the field of hepatobiliary surgery."

"Speaking of which, this Wu Ting is from the same hospital as my nephew, Jiang Ming. They’re colleagues. Jiang Ming has recommended him to me before as well."

"It’s just a pity that Dr. Wu’s area of research is in hepatobiliary."

Scholar Jiang was the pinnacle of the cardiovascular field, while Wu Ting knew nothing about it. No matter how talented he was, Scholar Jiang couldn’t guide him.

Speaking of research, Scholar Zeng asked,

"Keji, you recently took on a key project for the national ’14th Five-Year Plan.’ How is the Hybrid Technology research progressing?"

Jiang Keji was conducting "The Application of Hybrid Technology in Cardiovascular Surgery." The so-called Hybrid Technology is a new method for treating multi-vessel coronary heart disease that combines minimally invasive direct coronary artery bypass (MIDCAB) surgery with percutaneous coronary intervention (PCI).

This project was extremely complex and profound, and it represented the cutting edge of international cardiovascular surgery.

It also involved aspects of cardiac interventional stents and heart valve transplantation and repair, including treatment for aortic stenosis.

Jiang Keji sighed.

"The main difficulty we’re facing is that our vascular stent technology has hit a bottleneck. Our team’s drug-eluting stents have made some progress, but we still have no good solution for long-term postoperative restenosis. After all, intravascular stents have not yet been able to overcome long-term thrombotic events."

"Moreover, removing a stent after it has been inserted always carries significant clinical risk."

"If only there were a vascular stent made from a completely new material, one that could degrade on its own inside the vessel, allowing the blood vessel to completely return to its natural physiological structure and function after it has recovered and remodeled."

However, Scholar Jiang also understood that an innovation of this magnitude in intravascular stents couldn’t be achieved by clinical medical experts alone. It would require a collaborative research project supported by scientists in the field of material science.

Interdisciplinary research within medicine was already difficult, let alone between two completely different major fields of study.

Scholar Zeng agreed wholeheartedly.

"Indeed. What you’ve said, Keji, is exactly what I value as well. Modern medicine truly needs more talented individuals who can specialize in interdisciplinary fields."

"Speaking of which, this Dr. Wu Ting is doing a fantastic job."

"In fact, this clinical guideline of his is only the first phase of his research project. I’ve been following his paper in *Cell*. If he can complete this entire project, it will be an extraordinary accomplishment."

"His ability to achieve such results is a product of his work at the intersection of immunology and hepatobiliary surgery."

Hearing such high praise from Scholar Zeng, Scholar Jiang’s interest in Wu Ting was piqued.

An idea began to form in his mind. ’This Wu Ting started in the emergency department and is now dedicated to studying hepatobiliary surgery. This suggests he has potential and opportunities in the field of cardiovascular surgery as well.’

’The emergency department has its own emergency cardiovascular surgery unit. If I could encourage and guide him, perhaps Wu Ting’s solid fundamentals and exceptional clinical skills could lead to some achievements in cardiovascular surgery in the future.’

Of course, for Wu Ting to have already achieved so much in hepatobiliary surgery was no small feat, and he didn’t expect him to be able to get started in cardiovascular surgery anytime soon.

But he was still young. ’I can give him a few opportunities.’

Scholar Jiang had the confidence and standing to do so. After all, Fuwai Cardiovascular Surgery was top-tier in all of the Jin Country.

Fuwai Hospital was also a major national base for cardiovascular medical care, research, clinical practice, prevention, and talent development. At the same time, it was home to the Jin Country Cardiovascular Technology Collaborative Training Center, the National Research Center for Clinical Trials of New Cardiovascular Drugs, the Health Bureau’s Cardiovascular Disease Prevention and Control Research Center, and the World Health Organization’s Collaborating Centre for Research and Training in Cardiovascular Diseases.

Of course, for now, Wu Ting was still a layman in the field of cardiovascular surgery. Scholar Jiang wouldn’t rush his development; he could offer some guidance and patiently look out for him.

Once he had some foundational knowledge, in three to five years, when his comprehensive skills met the standard, only then would he be qualified to come to Fuwai for comprehensive, systematic advanced training.

After all, Fuwai Cardiovascular Surgery was where the Jin Country’s top cardiovascular surgery elites gathered. Without a certain level of skill, even someone personally recommended by Scholar Jiang wouldn’t be able to last.

It wasn’t as if Scholar Jiang was against promoting his own relatives; otherwise, Jiang Ming wouldn’t have had so many opportunities. However, the prerequisite for being given a chance was having the basic skills and qualifications oneself.

After chatting for a while longer, the two of them returned to the next session of the conference.

Another half hour passed, and the conference entered its intermission.

During the intermission, the inner area of the conference hall was opened to attendees from the outer areas.

At this time, the conference also provided an opportunity for some of the attending experts to present and exchange ideas, allowing them to report on, demonstrate, and share their current work.

And Wu Ting, with the recommendation and support of Dean Liu Rong and other senior directors, secured an opportunity to give a presentation.

Wu Ting had been waiting for this moment for a long time.